This is a standard, routine proxy filing with no surprises. Traders should focus on upcoming clinical trial data or financial results for potential market-moving information. The recent insider selling activity noted in the market snapshot may warrant monitoring but is not directly related to this filing.
Price Chart
Executive Summary
Beam Therapeutics Inc. (BEAM) has filed its definitive proxy statement (DEFA14A) for the 2026 annual meeting. The filing is routine and includes standard disclosures about director elections, executive compensation, and shareholder proposals. There is no activist campaign or significant corporate action disclosed in this filing.
Key Facts
- Routine proxy filing for annual meeting
- No activist campaign or dissident slate
- Standard disclosures about governance and compensation
- No material financial information or strategic changes disclosed
Financial Impact
No direct financial impact from this filing
Risk Factors
- Potential for activist involvement if performance continues to lag
- Clinical trial risks not disclosed in this governance filing
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001193125-26-161541 |
| Document: 0001193125-26-161541-index-headers.html | 0001193125-26-161541 |
| Document: 0001193125-26-161541-index.html | 0001193125-26-161541 |
| Document: 0001193125-26-161541.txt | 0001193125-26-161541 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 15, 2026 6w ago | Institutional Cluster | $27.10 $23.22 | ▼ −14.32% | ▼ −12.34% | $24.50 (−9.59%) |
Jul 2, 2026 13w ago | Insider Cluster | $34.79 $26.49 | ▼ −23.86% | ▼ −23.44% | $24.50 (−29.58%) |
Jul 1, 2026 13w ago | Insider Cluster | $33.48 $26.02 | ▲ +22.28% | ▲ +20.10% | $24.50 (+26.82%) |
May 12, 2026 20w ago | Press Release | $31.58 $29.49 | ▼ −6.62% | ▼ −4.89% | $24.50 (−22.42%) |
Apr 17, 2026 24w ago | DEFA14A | $31.19 $26.81 | ▼ −14.04% | ▼ −18.25% | $24.50 (−21.45%) |
Mar 25, 2026 27w ago | Press Release | $23.12 $30.16 | ▲ +30.45% | ▲ +22.59% | $24.50 (+5.97%) |
Mar 5, 2026 30w ago | 8-K | $26.54 $24.23 | ▼ −8.70% | ▼ −6.66% | $24.50 (−7.69%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access